Stanford University
Showing 201-292 of 292 Results
-
Bruce Koch, Ph.D.
Director, High-Throughput Screening
Current Role at StanfordHead, ChEM-H/CSB High Throughput Screening Knowledge Center (HTSKC)
Staff Co-lead, IMA HTS Module
Adviser to the SPARK Program -
Bob Kocher
Adjunct Professor, Health Policy
BioBob Kocher, MD is a Partner at Venrock and focuses on healthcare IT and services investments. He currently serves on the Boards of Devoted Health, Virta Health, Aledade, Lyra Health, Sitka, Need, Accompany Health, and Premera Blue Cross. He is a Board Observer at SmithRx, Stride, Suki, and The Public Health Company and previously Included Health (Grand Rounds + Doctor on Demand) and Castlight.
He is an Adjunct Professor at Stanford University School of Medicine and a Non-Resident Senior Fellow and Advisory Board Member at the Leonard D. Schaeffer Center for Health Policy and Economics at USC. He also serves on the Advisory Board of the National Institute of Healthcare Management (NIHCM).
Previously, Bob served in the Obama Administration as Special Assistant to the President for Healthcare and Economic Policy on the National Economic Council, as a Partner at McKinsey & Company, and is an internal medicine doctor. -
Kiran Kocherlakota
Director, Proposal Development Office, SoM Proposal Development Office
Current Role at StanfordDr. Kiran Kocherlakota is dedicated to empowering research faculty members to effectively compete for coveted funding opportunities
-
Robert Koegel
Senior Research Scientist, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
Current Role at StanfordSenior Research Scholar. (1) Conducting and publishing research related to the education, understanding, and treatment of autism; (2) Training professionals and family members in Pivotal ResponseTreatment.
-
Eric Koenig Gonzalez
Casual - Non-Exempt, Epidemiology and Population Health
BioEric is an undergraduate Computer Engineering student currently interning at the Epidemiology and Population Health Department. Currently working on developing the back end of the systems used for the Food for Health Equity Lab.
-
Jayme Koltsov, PhD
Biostatistician 3, Orthopaedic Surgery
BioDr. Koltsov is an expert in clinical and translational orthopaedic research design and biostatistics with an incredibly unique and valuable combination of skill-sets. Her foundation from her Ph.D. in orthopaedic biomechanics provides an understanding of the underlying anatomy, pathology, and mechanics not typical for a biostatistician. This background empowers effective and efficient communication with clinicians and scientists and enables Dr. Koltsov to develop study designs and analytic strategies exceptionally tailored to the physical orthopaedic problems under investigation.
Dr. Koltsov has an extensive knowledge base in research methodology and statistical methods honed from her PhD onward, including univariate statistics (parametric, non-parametric, and categorical); survival analysis (Kaplan Meier and Cox proportional hazards); multivariable and longitudinal data analyses (logistic regression, generalized linear modeling, linear mixed models, and generalized estimating equations); quasi-experimental techniques for reducing bias (propensity score matching and inverse probability treatment weighting); patient reported outcome design and validation; and healthcare economic analysis. Over the past 6 years, Dr. Koltsov has developed a successful track record of collaborations with clinicians and scientists to lead and facilitate high-quality clinical, translational, and health services research spanning multiple orthopaedic disciplines, including spine, arthroplasty, foot and ankle, upper extremity, trauma, sports medicine, pediatrics, rheumatology, rehabilitation, and biomechanics. -
Rohini Kosoglu
Biodesign Collaborator, School of Medicine - MDRP'S - Biodesign Program
BioRohini Kosoglu is a leading national expert on domestic policy and veteran of the White House, Congress, and presidential campaigns. She currently serves as a Policy Fellow at the Stanford Institute for Human-Centered Artificial Intelligence (HAI) and Director of Public Policy and Political Affairs at the Stanford Byers Center for Biodesign. She is also a Venture Partner at Fusion Fund, a venture firm that focuses on early-stage technology and health care investments. Kosoglu has been at the forefront of driving transformative change in social, technology, and economic policy over the last two decades. She also has the distinction of being the first South Asian American woman to hold the roles of both Domestic Policy Advisor to the Vice President and Chief of Staff in the United States Senate.
Kosoglu recently served as Deputy Assistant to the President and Domestic Policy Advisor to the Vice President. In this role, Kosoglu became the first Asian American woman to hold this position. She led and promoted initiatives on behalf of the President and Vice President to strengthen democracy, advance gender and racial equity, and create economic mobility for millions of American workers and families. Kosoglu also served as a key advisor during the creation and implementation of the American Rescue Plan, including the national response to the COVID-19 crisis, the CHIPS Act, the AI Bill of Rights, the bipartisan infrastructure law and the Cancer Moonshot. On behalf of the Vice President, she helped forge a number of public-private partnerships in the White House, ultimately driving billions of private sector dollars towards national priorities of the President and Vice President and leveraged the strengths of both the government and private-sector. Vice President Harris praised Kosoglu as “a brilliant and trusted leader” who “brought vision, strategic judgement, and a depth of experience as our Administration has addressed some of the most urgent challenges facing our nation.”
Earlier, Kosoglu made history as the first South Asian American woman to serve as Chief of Staff in the United States Senate under then-U.S. Senator Kamala Harris. She managed hearing preparations for some of the highest-profile Senate hearings over the last decade including investigations around data privacy, cybersecurity, and social media interference during the 2016 U.S. presidential election, as well as Supreme Court nomination hearings. Additionally, under her organizational leadership, the Joint Center for Political and Economic Studies named Harris’ office under Kosoglu's tenure as the most diverse in the U.S. Senate.
Kosoglu’s career in the United States Congress has also included over a decade of leadership positions crafting social, economic, and technology policy initiatives with senior Democratic Senators, including U.S. Senator Michael Bennet of Colorado and U.S. Senator Debbie Stabenow of Michigan. Notably, Kosoglu was a key negotiator during the passage of the historic Affordable Care Act. She also was a lead negotiator and drafter during the reform of the Food and Drug Administration which led to landmark designations for approval of innovative drugs and devices, known today as Breakthrough Therapies and Breakthrough Devices, respectively, as well as laws to strengthen patient-centered care in the 21st Century Cures Act.
Kosoglu was a former resident fellow at the Harvard Institute of Politics at the Kennedy School and received her bachelor’s degree with honors from the University of Michigan and a master’s degree from George Washington University. She serves on several nonprofit boards and advises across the public and private sectors. -
Shaila R. Kotadia
Director of Justice, Equity, Diversity, and Inclusion, School of Medicine - Human Resources Group
Current Role at StanfordDirector of Justice, Equity, Diversity, and Inclusion, School of Medicine Human Resources Group
-
Bartlomiej Kowalski
Software Dvlpr 3, Ophthalmology Research/Clinical Trials
BioI am a senior software engineer in the Dubra Lab at The Byers Eye Institute, where I work on developing novel ophthalmic imaging instrumentation for improving the understanding, diagnosing and management of eye disease.
My interest in computer science started early in life and led me to obtain master’s degree at Czestochowa University of Technology (Poland). After graduating, I contributed to the advancing of spectral domain optical coherence tomography (OCT) and pioneering of swept-source OCT for retinal imaging as part of Canon Ophthalmic Technologies (Poland). This work resulted in two commercially successful instruments, the Xephilio OCT-A1 and the Xephilio OCT-S1, which are sold worldwide.
My current work focuses on innovations that allow the translation of Adaptive Optics Ophthalmoscopy from a research tool into a mature technology that improves eye care. -
Beatrix Krause-Sorio
Physical Science Research Scientist, Rad/Radiological Sciences Laboratory
Current Role at StanfordPhysical Science Research Scientist
-
Miri Krupkin
Basic Life Research Scientist, Structural Biology
BioMy background is deeply rooted in structural biology and biochemistry of proteins and RNA. My current research focuses on understanding the regulatory role of RNA structures in HIV infection. To this end, I am focusing on revealing the conformational landscape of viral RNA during reverse transcription. I am also devoted to promoting science education and outreach.
-
Karteek Kunala
Research Engineer, Ophthalmology Research/Clinical Trials
BioMy current interests are in development of design and instrumentation of pre-clinical vision devices, to conduct non-invasive in vivo retinal imaging. I studied Physics with a concentration in optics during my time at University of Hyderabad, India and received a bachelors and masters degree in 2014. I then moved to USA to continue working in the field of optics at University of North Carolina at Charlotte to pursue my PhD, working on nanofabrication of broadband anti-reflective structures. My interest in vision science started with my job at University of Rochester as a research scientist, where I was involved in developing optical imaging tools using adaptive optics to study retinal diseases. My work was focused on development of fluorescence lifetime imaging techniques in humans and two photon fluorescence microscopy in mouse.
